| MEA-I | multiple endocrine adenomatosis type I |
|---|---|
| ML | I, II, III, IV mucolipidosis I, II, III, IV |
| ALL | Acute Lymphocytic Leukemia 형태학적 분류 L1; Small, Homogenous(... |
| MEDAC Syndrome | Multiple-Endocrine Deficiency Autoimmune-Candidiasis |
| MEA | male-enhanced antigen; Medical Exhibition Association; mercaptoethylamine; monoethanolamine; multipl... |
| HTLV-III | Human T-cell leukaemia virus type III |
|---|---|
| HTLV-III | Human T-lymphotropic virus type III |
| FN III | fibronectin type III |
| HTLV-III/LAV | human T cell lymphotropic virus type III/lymphadenopathy associated virus |
| HTLV-III/LAV | human T lymphotrophic virus type III/lymphadenopathy-associated virus |
| diagnostic techniques, endocrine | Methods and procedures for the diagnosis of diseases or dysfunction of the endocrine glands or demonstration of their physiological processes. (12 Dec 1998) |
|---|---|
| endocrine | Pertaining to internal secretions, hormonal. Compare: exocrine. Origin: Gr. Krinein = to separate (18 Nov 1997) |
| endocrine cells of gut | Cells found throughout the lining of the gastrointestinal tract that contain regulatory peptide hormones and/or biogenic amines. The substances are located in secretory granules and act in an endocrine or paracrine manner. Some of these substances are also found in neurons in the gut. There are at least 15 different types of endocrine cells of the gut. Some take up amine precursors and have been called apud cells. However, most endocrine cells of the gut apparently have endodermal rather than neuroectodermal origin, so the relationship with apud cells is not clear. (12 Dec 1998) |
| endocrine disorders | Disorders which involve the over-production or under-production of hormone substances from an endocrine gland. Some examples include diabetes, hypothyroidism, hyperthyroidism, hyperparathyroidism, Cushing's disease, Cushing's syndrome and acromegaly. (27 Sep 1997) |
| endocrine exophthalmos | Exophthalmos associated with thyroid gland disorders. See: Graves' ophthalmopathy, Graves' orbitopathy. (05 Mar 2000) |
| endocrine gland | Organs or gland that secrete regulatory substances directly into the circulation and not through a duct. Examples are pituitary, thyroid, parathyroid, adrenal glands, ovary and testis, placenta and beta cells of pancreas. (27 Sep 1997) |
| endocrine gland neoplasms | Tumour or cancer of the endocrine glands in general or unspecified. (12 Dec 1998) |
| endocrine glands | Ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions. (12 Dec 1998) |
| endocrine hormones | Hormones produced by the endocrine system. Compare: tissue hormones. (05 Mar 2000) |
| endocrine manipulation | Treating breast cancer by changing the hormonal balance of the body to prevent hormone dependent cancer cells from multiplying. (09 Oct 1997) |
| endocrine ophthalmopathy | Exophthalmos caused by increased water content of retro-ocular orbital tissues; associated with thyroid disease, usually hyperthyroidism. Synonym: endocrine ophthalmopathy, Graves' orbitopathy. (05 Mar 2000) |
| endocrine surgical procedures | Surgery performed on any endocrine gland. (12 Dec 1998) |
| endocrine system | The system of glands that release their secretions (hormones) directly into the circulatory system. In addition to the endocrine glands, included are the chromaffin system and the neurosecretory systems. (12 Dec 1998) |
| tuberculosis, endocrine | Tuberculous infection of the endocrine glands. (12 Dec 1998) |
| angiotensin III | <chemical> A heptapeptide formed by the enzymatic hydrolysis of angiotensin II. It has greater activity than angiotensin II for stimulating aldosterone synthesis and in the release of prostaglandins but only 20% of the pressor activity. Chemical name: Angiotensin II, 1-de-L-aspartic acid- (12 Dec 1998) |